Kaj Blennow Selected Research

Alzheimer Disease (Alzheimer's Disease)

11/2022	Diagnostic value of serum versus plasma phospho-tau for Alzheimer's disease.
10/2022	Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
10/2022	Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
8/2022	Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
6/2022	Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models.
6/2022	Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
5/2022	Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging.
5/2022	Cross-sectional associations of CSF tau levels with Rey's AVLT: A recency ratio study.
5/2022	Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer's disease biomarkers.
4/2022	Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaj Blennow Research Topics

Disease

741	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 03/2000
243	Dementia (Dementias) 11/2022 - 03/2000
221	Cognitive Dysfunction 04/2022 - 01/2003
90	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 01/2002
49	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2004
47	Atrophy 02/2022 - 01/2007
45	Amyloid Plaque 01/2022 - 07/2002
44	Neuroinflammatory Diseases 11/2022 - 12/2009
42	Inflammation (Inflammations) 11/2022 - 09/2004
39	Brain Injuries (Brain Injury) 12/2022 - 02/2003
36	Disease Progression 01/2022 - 07/2002
31	Frontotemporal Dementia (Semantic Dementia) 10/2022 - 01/2002
28	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2022 - 01/2004
25	Multiple Sclerosis 10/2022 - 03/2007
25	Amyloidosis 06/2022 - 07/2013
22	Stroke (Strokes) 01/2022 - 01/2006
17	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 10/2021 - 03/2002
15	COVID-19 11/2022 - 01/2020
15	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 12/2009
13	Parkinsonian Disorders (Parkinsonism) 01/2022 - 02/2003
12	Schizophrenia (Dementia Praecox) 10/2022 - 01/2002
12	Neurobehavioral Manifestations 06/2022 - 12/2011
12	Normal Pressure Hydrocephalus 02/2022 - 04/2013
12	Nervous System Diseases (Neurological Disorders) 01/2022 - 10/2008
12	Delirium 01/2022 - 01/2017
11	Tauopathies 10/2021 - 11/2012
10	Heart Arrest (Cardiac Arrest) 06/2022 - 01/2011
10	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022 - 11/2012
10	Down Syndrome (Down's Syndrome) 01/2022 - 01/2007
10	Ischemic Stroke 12/2021 - 01/2014
10	Brain Concussion (Cerebral Concussion) 01/2021 - 04/2013
9	Brain Diseases (Brain Disorder) 01/2022 - 07/2013
8	Wounds and Injuries (Trauma) 03/2022 - 02/2003
8	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2021 - 11/2012
8	Alcoholism (Alcohol Abuse) 01/2012 - 11/2002
7	Encephalitis (Encephalitis, Rasmussen) 11/2022 - 11/2017
7	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 11/2022 - 04/2004
7	Genetic Risk Score 03/2022 - 01/2017
7	Gliosis 12/2021 - 01/2018
7	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2021 - 07/2010
7	Neoplasms (Cancer) 10/2021 - 04/2013
7	Chronic Traumatic Encephalopathy 01/2020 - 05/2015
6	Infarction (Infarctions) 11/2022 - 07/2010
6	Prion Diseases (Transmissible Spongiform Encephalopathies) 06/2022 - 05/2002
6	Lewy Body Disease (Lewy Body Dementia) 01/2022 - 01/2011
6	Emergence Delirium 01/2022 - 01/2019
6	Infections 10/2021 - 06/2010
6	Major Depressive Disorder (Major Depressive Disorders) 10/2021 - 04/2010
6	Hypertension (High Blood Pressure) 01/2021 - 01/2005
6	Craniocerebral Trauma (Head Injury) 01/2020 - 08/2009
6	Huntington Disease (Huntington's Disease) 01/2020 - 01/2017
6	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2019 - 01/2002
5	Out-of-Hospital Cardiac Arrest 12/2022 - 02/2014

Drug/Important Bio-Agent (IBA)

699	Biomarkers (Surrogate Marker)IBA 12/2022 - 03/2000
326	Amyloid (Amyloid Fibrils)IBA 11/2022 - 01/2003
193	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2002
110	Amyloid beta-PeptidesIBA 06/2022 - 01/2002
82	Apolipoproteins E (ApoE)IBA 03/2022 - 04/2003
74	Peptides (Polypeptides)IBA 05/2022 - 01/2005
58	NeurograninIBA 06/2022 - 11/2010
41	Glial Fibrillary Acidic ProteinIBA 11/2022 - 05/2007
40	ApolipoproteinsIBA 01/2022 - 11/2004
37	tau Proteins (tau Protein)IBA 01/2022 - 08/2002
34	Pharmaceutical PreparationsIBA 10/2021 - 09/2005
33	Biological ProductsIBA 06/2022 - 01/2002
24	Amino Acids FDA Link 01/2022 - 08/2002
20	EnzymesIBA 01/2022 - 09/2003
20	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 10/2021 - 01/2016
20	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2021 - 09/2003
18	Protein Isoforms (Isoforms)IBA 01/2022 - 05/2002
17	Threonine (L-Threonine)FDA Link 10/2022 - 08/2002
14	SynucleinsIBA 04/2021 - 01/2014
12	Phosphopyruvate Hydratase (Enolase)IBA 04/2022 - 02/2003
12	CytokinesIBA 01/2022 - 03/2002
12	LipidsIBA 01/2022 - 01/2005
12	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2004
9	Interleukin-8 (Interleukin 8)IBA 11/2021 - 10/2014
9	CholesterolIBA 01/2021 - 01/2003
8	Fatty Acid Binding Protein 3IBA 03/2022 - 01/2010
8	Complement System Proteins (Complement)IBA 01/2022 - 05/2007
8	Serum AlbuminIBA 01/2022 - 04/2010
8	ImmunosorbentsIBA 07/2021 - 09/2003
7	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2003
7	Monoclonal AntibodiesIBA 01/2022 - 04/2010
7	Chitinase-3-Like Protein 1IBA 10/2021 - 01/2016
7	Flavin-Adenine Dinucleotide (FAD)IBA 01/2021 - 01/2017
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020 - 03/2002
6	UbiquitinIBA 11/2022 - 11/2005
6	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2019
6	Cholinergic Agents (Cholinergics)IBA 10/2021 - 01/2013
6	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 11/2005
6	AntibodiesIBA 04/2021 - 07/2012
6	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 04/2010
6	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020 - 10/2003
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 02/2003
6	AcidsIBA 01/2017 - 01/2005
6	EsterasesIBA 01/2012 - 07/2002
5	Indicators and Reagents (Reagents)IBA 02/2022 - 11/2013
5	EpitopesIBA 02/2022 - 01/2004

Therapy/Procedure

47	Therapeutics 01/2022 - 11/2007